| Application no. and date | 10788479.3 (espacenet) (Federated) (European Patent Register), 20101206 | | Patent/reg. no. and date | DK/EP 2509963, 20151125 | | Publication date | 20121017 | | Priority no. and date | US 267155 P, 20091207 | | EP pub. no. and date |
EP 2509963 20121017 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | T5095DK00 | | Inventor | BERGHAUSEN, Joerg, Novartis Pharma AG
Werk Klybeck
Postfach
CH-4002 Basel, CH,
KAPA, Prasad, Koteswara, Novartis
One Health Plaza
East Hanover, NJ 07936, US,
MCKENNA, Joseph, Novartis
One Health Plaza
East Hanover
New Jersey 07936, US,
SLADE, Joel, Novartis
One Health Plaza
East Hanover
New Jersey 07936, US,
WU, Raeann, Novartis
One Health Plaza
East Hanover
New Jersey 07936, US,
DU, Zhengming, Novartis
One Health Plaza
East Hanover
New Jersey 07936, US,
STOWASSER, Frank, Novartis Pharma AG
Werk Klybeck
Postfach
CH-4002 Basel, CH | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 239/48 (2006.01) | | Title | KRYSTALLINSKE FORMER AF 3-(2,6-DICHLOR-3,5-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA OG SALTE DERAF | | Int. application no. | US2010059108 | | Int. publication no. | WO2011071821 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
